NEVRO CORP SEC Filings

Filed On	Filing
14 Aug 2025	SCHEDULE 13G/A
13 Aug 2025	SCHEDULE 13G/A
15 May 2025	SCHEDULE 13G/A
13 May 2025	SCHEDULE 13G
14 Apr 2025	15-12G
07 Apr 2025	EFFECT
04 Apr 2025	SCHEDULE 13D/A
03 Apr 2025	Form 4: Grossman D Keith, Director Returned 228,552 shares to the issuer
03 Apr 2025	Form 4: Kosaraju Sridhar, Director Returned 46,575 shares to the issuer
03 Apr 2025	Form 4: mcCormick Shawn, Director Returned 46,035 shares to the issuer
03 Apr 2025	Form 4: Siegel Susan E, Director Returned 31,961 shares to the issuer
03 Apr 2025	Form 4: Karros Kirt P, Director Returned 17,452 shares to the issuer
03 Apr 2025	Form 4: Thornal Kevin R, Director Returned 852,337 shares to the issuer
03 Apr 2025	Form 4: Prange Karen, Director Returned 33,948 shares to the issuer
03 Apr 2025	Form 4: Oboyle Kevin C, Director Returned 43,396 shares to the issuer
03 Apr 2025	Form 4: MacLeod Roderick H., SVP, Chief Financial Officer Returned 350,663 shares to the issuer
03 Apr 2025	Form 4: Demane Michael F, Director Returned 503,618 shares to the issuer
03 Apr 2025	Form 4: Siller Greg, SVP & Chief Commercial Officer Returned 195,598 shares to the issuer
03 Apr 2025	Form 4: Weatherman Elizabeth H, Director Returned 86,171 shares to the issuer
03 Apr 2025	Form 4: Christoforou Christofer, SVP, Chief Operating Officer Returned 363,765 shares to the issuer

Comments